Get your free Purchase Recommendation Research Report Sample



  1. In this special report you will learn about our investing philosophy and read more about: 

    1. Why we believed the market misunderstood Bioverativ’s potential

    2. Our financial projections and modelling

    3. Our valuation analysis that supported our achieved $87 price target (and +95% return)


Subscribers to The Turnaround Letter receive access to our institutional-quality research tools to help make the most informed investing choices. Included are detailed research reports for new Buy-rated companies, updates on portfolio companies, lists of new catalyst-driven stocks and other research describing why we believe that a company is a good turnaround choice. In this free recommendation report, you can see first-hand the research and methodology we applied to selecting Bioverativ, which went on to produce a 95% return.



About The Turnaround Letter:

Mission & History

The Turnaround Letter has been a family business since 1986. Founded by George Putnam, for 33 years and counting our goal is to help members find highly profitable investment ideas backed up by detailed and thorough research. 

Investing Philosophy

Our investment philosophy is to select overlooked companies with real value and imminent changes that can significantly improve the companies’ prospects and profit potential.

Our timeless investing process, consistently applied, has helped drive The Turnaround Letter’s market-beating investment returns. We hope to continue providing these kinds of returns to you over the next 33 years.